EP2119445A4 - Prophylactic agent for autoimmune disease - Google Patents

Prophylactic agent for autoimmune disease

Info

Publication number
EP2119445A4
EP2119445A4 EP08710936A EP08710936A EP2119445A4 EP 2119445 A4 EP2119445 A4 EP 2119445A4 EP 08710936 A EP08710936 A EP 08710936A EP 08710936 A EP08710936 A EP 08710936A EP 2119445 A4 EP2119445 A4 EP 2119445A4
Authority
EP
European Patent Office
Prior art keywords
autoimmune disease
prophylactic agent
prophylactic
agent
autoimmune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08710936A
Other languages
German (de)
French (fr)
Other versions
EP2119445A1 (en
Inventor
Hiroshi Kawakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Megmilk Snow Brand Co Ltd
Original Assignee
Megmilk Snow Brand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megmilk Snow Brand Co Ltd filed Critical Megmilk Snow Brand Co Ltd
Publication of EP2119445A1 publication Critical patent/EP2119445A1/en
Publication of EP2119445A4 publication Critical patent/EP2119445A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP08710936A 2007-02-08 2008-02-07 Prophylactic agent for autoimmune disease Withdrawn EP2119445A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007028809A JP2008189637A (en) 2007-02-08 2007-02-08 Prophylactic of autoimmune disease
PCT/JP2008/052057 WO2008096826A1 (en) 2007-02-08 2008-02-07 Prophylactic agent for autoimmune disease

Publications (2)

Publication Number Publication Date
EP2119445A1 EP2119445A1 (en) 2009-11-18
EP2119445A4 true EP2119445A4 (en) 2012-02-01

Family

ID=39681730

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08710936A Withdrawn EP2119445A4 (en) 2007-02-08 2008-02-07 Prophylactic agent for autoimmune disease

Country Status (8)

Country Link
US (1) US20100316621A1 (en)
EP (1) EP2119445A4 (en)
JP (1) JP2008189637A (en)
KR (1) KR20090108088A (en)
CN (1) CN101631555B (en)
AU (1) AU2008212212A1 (en)
CA (1) CA2677233A1 (en)
WO (1) WO2008096826A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI589299B (en) 2011-10-11 2017-07-01 再生元醫藥公司 Compositions for the treatment of rheumatoid arthritis and methods of using same
US20160067315A1 (en) 2013-04-09 2016-03-10 The University Of Tokyo Inhibitor of extracellular trap formation in leukocytes
KR101583734B1 (en) 2014-09-01 2016-01-08 강원대학교 산학협력단 Composition with lactoferrin and retinoic acid for the prevention or treatment of immune disease
WO2016056665A1 (en) * 2014-10-08 2016-04-14 学校法人慶應義塾 White blood cell extracellular trap formation inhibitor
JP6941417B2 (en) * 2016-02-04 2021-09-29 雪印メグミルク株式会社 Cartilage function improver

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0629350A1 (en) * 1993-06-16 1994-12-21 Sandoz Nutrition Ltd. Milk protein hydrolysates
WO1998031239A1 (en) * 1997-01-17 1998-07-23 Nederlands Instituut Voor Zuivelonderzoek Method for the selective degradation of milk protein in the presence of other milk proteins
WO2005117933A1 (en) * 2004-05-27 2005-12-15 Campina Nederland Holding B.V. Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a dpp-iv mediated condition
WO2006068480A2 (en) * 2004-12-23 2006-06-29 Campina Nederland Holding B.V. Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use
WO2007012748A2 (en) * 2005-07-29 2007-02-01 Compagnie Laitiere Europeenne Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases
EP1800675A1 (en) * 2005-12-23 2007-06-27 Nutricia N.V. Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition
WO2007103525A2 (en) * 2006-03-09 2007-09-13 Glanbia Nutritionals (Ireland) Limited Cationic whey protein composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE901672A (en) 1985-02-07 1985-08-07 Oleofina Sa Milk protein purificn. - by adsorption on acidic polysaccharide gel
US5268170A (en) 1986-09-09 1993-12-07 Yeda Research And Development Co., Ltd. Methods of treatment and diagnosis of autoimmune diseases, especially arthritic conditions
JPH0725800B2 (en) 1987-04-10 1995-03-22 雪印乳業株式会社 Method for separating and purifying lactoferrin from milk using sulfate esterification product
FR2616628B1 (en) 1987-06-19 1989-09-29 Entremont Sa PROCESS FOR EXTRACTING WHEY PROTEINS BY ADSORPTION AND ELUTION
NL8703107A (en) 1987-12-22 1989-07-17 Nederlanden Staat POLYPEPTIDES AND DERIVATIVES THEREOF, AND THEIR USE THEREOF IN PHARMACEUTICAL AND DIAGNOSTIC PREPARATIONS.
US5578303A (en) 1989-03-14 1996-11-26 Yeda Research And Development Co. Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
JP2686831B2 (en) 1989-09-22 1997-12-08 雪印乳業株式会社 Method for separating, purifying, and collecting iron-binding protein
JP3184923B2 (en) * 1992-01-08 2001-07-09 ビオ セレ ラボラトワール エス ア Anti-rheumatic drug
JPH05202098A (en) 1992-01-29 1993-08-10 Snow Brand Milk Prod Co Ltd Production of physiologically active substance from lactic material
JP3112637B2 (en) * 1994-09-30 2000-11-27 雪印乳業株式会社 Bone strengthener
US5674995A (en) * 1995-06-07 1997-10-07 Gen-Probe Incorporated Oligonucleotides specific for cytokine signal transducer gp130 mRNA
AU705122B2 (en) * 1995-06-07 1999-05-13 Gen-Probe Incorporated Oligonucleotides specific for cytokine signal transducer gp130 mRNA
US5747470A (en) * 1995-06-07 1998-05-05 Gen-Probe Incorporated Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA
JPH10279479A (en) * 1997-04-04 1998-10-20 Sagami Chem Res Center Suppressant of interleukin 6 production
CN1114618C (en) * 2000-05-19 2003-07-16 程伶辉 Trivalent chromium compound and its milk product and making process
FR2841747B1 (en) * 2002-07-02 2004-08-20 Cie Laitiere Europeenne MILK PROTEIN ISOLATE AND PROCESS FOR ITS PREPARATION
JP3738268B2 (en) * 2003-02-24 2006-01-25 森永乳業株式会社 Interleukin-6 production inhibitor
EP1623718B1 (en) * 2003-05-07 2011-01-05 Snow Brand Milk Products Co., Ltd. Skin collagen production promoter
WO2004103285A2 (en) * 2003-05-14 2004-12-02 Agennix Incorporated Lactoferrin in the treatment of diabetes mellitus

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0629350A1 (en) * 1993-06-16 1994-12-21 Sandoz Nutrition Ltd. Milk protein hydrolysates
WO1998031239A1 (en) * 1997-01-17 1998-07-23 Nederlands Instituut Voor Zuivelonderzoek Method for the selective degradation of milk protein in the presence of other milk proteins
WO2005117933A1 (en) * 2004-05-27 2005-12-15 Campina Nederland Holding B.V. Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a dpp-iv mediated condition
WO2006068480A2 (en) * 2004-12-23 2006-06-29 Campina Nederland Holding B.V. Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use
WO2007012748A2 (en) * 2005-07-29 2007-02-01 Compagnie Laitiere Europeenne Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases
EP1800675A1 (en) * 2005-12-23 2007-06-27 Nutricia N.V. Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition
WO2007103525A2 (en) * 2006-03-09 2007-09-13 Glanbia Nutritionals (Ireland) Limited Cationic whey protein composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008096826A1 *

Also Published As

Publication number Publication date
CN101631555A (en) 2010-01-20
US20100316621A1 (en) 2010-12-16
AU2008212212A1 (en) 2008-08-14
EP2119445A1 (en) 2009-11-18
CA2677233A1 (en) 2008-08-14
CN101631555B (en) 2013-04-03
KR20090108088A (en) 2009-10-14
JP2008189637A (en) 2008-08-21
WO2008096826A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
GB2441650B (en) Dual release headrest
EP2089712A4 (en) Autoimmune disease biomarkers
GB0711952D0 (en) Microspheres
PL1981630T3 (en) Microspheres
ZA201003697B (en) Antiemetic-oral contraceptive combination
HK1139857A1 (en) Wrinkling-preventing and-modifying agent
EP2009465A4 (en) Mammography system
EP2236594A4 (en) Biofilm-removing agent
EP2183681A4 (en) Probability state models
EP2081453A4 (en) Push up bra
EP2057981A4 (en) Anti-wrinkle agent
EP2286836A4 (en) Immunostimulating agent
EP2059688A4 (en) Disconnect
EP2221057A4 (en) Sense-improving agent
EP2062892A4 (en) Hypertension-ameliorating agent
EP2119445A4 (en) Prophylactic agent for autoimmune disease
EP2030629A4 (en) Lipid-metabolism-improving agent
HK1142277A1 (en) Novel antiphlogistic-analgesic agent
EP2168955A4 (en) Sleep-improving agent
GB2443290B (en) Separation agent
EP2060263A4 (en) Lipid-metabolism-ameliorating agent
EP2172195A4 (en) Cholesterol-control agent
GB0701321D0 (en) Agent
GB0702498D0 (en) Foam
GB0702547D0 (en) Elevation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090805

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MEGMILK SNOW BRAND CO., LTD.

A4 Supplementary search report drawn up and despatched

Effective date: 20111230

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 19/02 20060101ALI20111223BHEP

Ipc: A61P 29/00 20060101ALI20111223BHEP

Ipc: A61P 37/02 20060101ALI20111223BHEP

Ipc: A61P 3/10 20060101ALI20111223BHEP

Ipc: A61K 38/44 20060101ALI20111223BHEP

Ipc: A61K 35/20 20060101AFI20111223BHEP

Ipc: A61K 38/01 20060101ALI20111223BHEP

Ipc: A61K 38/40 20060101ALI20111223BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20120712